FDA OKs Drug for Rare Lipid Disorder

(MedPage Today) -- The FDA has approved lomitapide (Juxtapid) as add-on therapy in patients with a genetic form of hypercholesterolemia. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/12/fda-oks-drug-for-rare-lipid-disorder.html